EUCRW (Eucrates Biomedical Acquisition) FCF Yield %: -1.49 (As of Sep. 09, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EUCRW Eucrates Biomedical Acquisition Corp EUCRW
22 GF Score
Price $0.00
! 2 Warning Signs
View Full Analysis

What is Eucrates Biomedical Acquisition FCF Yield %?

Eucrates Biomedical Acquisition EUCRW 22 FCF Yield % is -1.49 as of Sep. 09, 2026. GuruFocus rates EUCRW with a GF Score™ of 22/100. The stock has 2 warning signs investors should review.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Eucrates Biomedical Acquisition's Trailing 12-Month Free Cash Flow is $0.00 Mil, and Market Cap is $0.00 Mil. Therefore, Eucrates Biomedical Acquisition's FCF Yield % for today is -1.49%.

The historical rank and industry rank for Eucrates Biomedical Acquisition's FCF Yield % or its related term are showing as below:

EUCRW' s FCF Yield % Range Over the Past 10 Years
Min: -1.49   Med: 0   Max: 0
Current: -1.49

EUCRW's FCF Yield % is not ranked
in the Diversified Financial Services industry.
Industry Median: -0.35 vs EUCRW: -1.49

Eucrates Biomedical Acquisition's FCF Margin % for the quarter that ended in Dec. 2022 was 0.00%.

Eucrates Biomedical Acquisition FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Eucrates Biomedical Acquisition FCF Yield % Related Terms

Eucrates Biomedical Acquisition FCF Yield % Historical Data

* Premium members only.

The historical data trend for Eucrates Biomedical Acquisition's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eucrates Biomedical Acquisition FCF Yield % Chart

Eucrates Biomedical Acquisition Annual Data
Trend Dec20 Dec21 Dec22
FCF Yield %
0.00 0.00 0.00

Eucrates Biomedical Acquisition Quarterly Data
Aug20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

EUCRW vs FXCO, AEHA, LMAO: FCF Yield % Comparison

For the Shell Companies subindustry, Eucrates Biomedical Acquisition's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eucrates Biomedical Acquisition FCF Yield % vs Diversified Financial Services Industry

For the Diversified Financial Services industry and Financial Services sector, Eucrates Biomedical Acquisition's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Eucrates Biomedical Acquisition's FCF Yield % falls into.


EUCRW
22GF Score
Eucrates Biomedical Acquisition Corp EUCRW
FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eucrates Biomedical Acquisition FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Eucrates Biomedical Acquisition's FCF Yield % for the fiscal year that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-0.63 /
=N/A%

Eucrates Biomedical Acquisition's annualized FCF Yield % for the quarter that ended in Dec. 2022 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.391 * 4 /
=N/A%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Yield % →
What does a FCF Yield % of -1.49 mean?
Eucrates Biomedical Acquisition (EUCRW) has a FCF Yield % of -1.49 as of Sep. 09, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Eucrates Biomedical Acquisition and its competitors.
Is Eucrates Biomedical Acquisition's FCF Yield % too high?
Eucrates Biomedical Acquisition's current FCF Yield % is -1.49. Overall, Eucrates Biomedical Acquisition has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Eucrates Biomedical Acquisition's FCF Yield % compare to FXCO and AEHA?
Eucrates Biomedical Acquisition's FCF Yield % of -1.49 can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Diversified Financial Services company?
A good FCF Yield % depends on the Diversified Financial Services industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Eucrates Biomedical Acquisition and its competitors. Eucrates Biomedical Acquisition's current FCF Yield % is -1.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eucrates Biomedical Acquisition stock overvalued right now?
Eucrates Biomedical Acquisition (EUCRW) has a current FCF Yield % of -1.49. The current FCF Yield % is -1.49. Eucrates Biomedical Acquisition's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Eucrates Biomedical Acquisition (EUCRW), the current FCF Yield % is -1.49 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Eucrates Biomedical Acquisition Business Description

Address 250 West 55th Street, Suite 13D, New York, NY, USA, 10019
Eucrates Biomedical Acquisition Corp is a blank check company.
22GF Score

Get the complete analysis for EUCRW

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price